Company / R&D Expense
CareDx, Inc. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$71.4M
FY2025
5-year range
$71.4M / $90.4M
FY2021-FY2025
Trend
-1.5%
vs FY2024
Sector context
#67 of 105
Health Care
What the data says
At $71M, CareDx, Inc.'s r&d expense ranks #67 of 105 in the Health Care sector. R&D Expense has declined for 3 consecutive years, from $90M in FY2022 to $71M in FY2025.
Based on SEC 10-K filings.
$71M in FY2025 with a 5-year CAGR of +7.9%.
Declined from $82M to $71M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -7.5%
- 5-Year CAGR
- +7.9%
- 10-Year CAGR
- -
Sector benchmark
#67 of 105 in Health CareTop 64% of 105This company $71.4M Sector average $284.2M
▼
-74.9% below sector average
Key checks
Key Insights
- CareDx, Inc.'s r&d expense has declined for 3 consecutive years.
- 5-year CAGR of +7.9%, indicating consistent growth.
- In FY2025, r&d expense decreased 1.5% year-over-year.
- Ranks #67 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $71.4M | -1.5% |
| FY2024 | $72.5M | -12.0% |
| FY2023 | $82.4M | -8.8% |
| FY2022 | $90.4M | +18.1% |
| FY2021 | $76.5M | +56.4% |
| FY2020 | $48.9M | +59.4% |
| FY2019 | $30.7M | +111.6% |
| FY2018 | $14.5M | +17.2% |
| FY2017 | $12.4M | +0.0% |
| FY2016 | $12.4M | +32.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026